SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-20-090201
Filing Date
2020-03-30
Accepted
2020-03-30 09:01:30
Documents
45
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d858310d10k.htm 10-K 901356
2 EX-23.1 d858310dex231.htm EX-23.1 2341
3 EX-31.1 d858310dex311.htm EX-31.1 10631
4 EX-31.2 d858310dex312.htm EX-31.2 10438
5 EX-32.1 d858310dex321.htm EX-32.1 3576
6 EX-32.2 d858310dex322.htm EX-32.2 3583
  Complete submission text file 0001193125-20-090201.txt   3405841

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hppi-20191231.xml EX-101.INS 568176
8 XBRL TAXONOMY EXTENSION SCHEMA hppi-20191231.xsd EX-101.SCH 30821
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20191231_cal.xml EX-101.CAL 22845
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20191231_def.xml EX-101.DEF 155821
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20191231_lab.xml EX-101.LAB 273615
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20191231_pre.xml EX-101.PRE 215163
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 20754288
SIC: 8731 Services-Commercial Physical & Biological Research